Cardiovascular

Latest News
December 20th 2024

ICYMI: AHA 2024 Scientific Session Highlights

December 19th 2024

Q&A: Dr Dan Bloomfield Elaborates on Novel Findings From AZALEA-TIMI 71 Trial, Future of FXI Inhibitor Abelacimab

December 17th 2024

Low Lp(a) Testing in ASCVD: Higher Levels in Black and Female Patients

December 11th 2024

Impact of Delayed Adoption of Novel Atrial Fibrillation Treatments

December 9th 2024

ICYMI: Highlights From ASPC Congress 2024

Advancements in Population Health Strategies for Cardiovascular Risk Management

Experts discuss how lipoproteins drive atherosclerotic heart disease, review the different guidelines and recommendations on Lp(a) testing, and insights from clinical trials.

Hands holding a heart with a heartbeat on it and the words AJMC Insights
Video Interviews
View All
December 20th 2024

Tackling CKM Syndrome as a Holistic Approach to a Growing Health Crisis

September 25th 2024

Greater Awareness, Community Empowerment Needed in CVD Prevention Efforts

September 3rd 2024

Ochsner Health's Connected MOM Program: Managing Hypertension During Pregnancy and Postpartum

September 3rd 2024

CMS Negotiated Drug Prices: Cardiologist's View on Affordability, Future Innovation

August 26th 2024

Dr Martha Gulati Previews ESC 2024: Obesity, Heart Failure, and the Ongoing Debate on HRT

July 8th 2024

2024 ASPC Congress on CVD Prevention to Be Held in August

April 24th 2024

Dr Rashon Lane Addresses How Racial, Ethnic Inequities Factor Into Cardiometabolic Health Care

September 30th 2023

Lack of Cardiovascular Trial Diversity Is an International Issue: Dr Shrilla Banerjee Gives UK Perspective

September 20th 2023

Dr Donna Fitzsimons: “Doctor Knows Best” Mindset Wanes as Patients Become More Self-Educated

September 16th 2023

Dr Milind Desai on VALOR-HCM: Primary and Secondary Effects Are Sustained While on Mavacamten

Podcasts
View All
May 30th 2024

From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care

May 10th 2022

For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management

February 22nd 2020

Podcast: This Week in Managed Care—Setbacks for Medicaid Work Rules and Other Health News

June 2nd 2019

Podcast: This Week in Managed Care—The $2 Million Gene Therapy and Other Health News

December 1st 2018

Podcast: This Week in Managed Care—CMS Drug Coverage Changes Draw Ire and Other Health News

November 18th 2018

Podcast: This Week in Managed Care—Cancer Is the New Leading Cause of Death and Other Health News

November 10th 2018

Podcast: This Week in Managed Care—Medicaid Expansion at the Ballot Box and Other Health News

June 17th 2017

Podcast: This Week in Managed Care - Dropped ACA Coverage, and Other News

Continuing Medical Education
View All
December 24th 2024

Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment

1.5 Credits / Cardiology, Neurology, Rare Diseases
December 24th 2024

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
December 24th 2024

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

1.0 Credit / Cardiology

More News

EKG heartbeat line | Image Credit: Jiva Core - stock.adobe.com
December 6th 2024

Acoramidis Sustains Benefits in Patients With ATTR-CM in Open-Label Extension Study

Brooke McCormick
Data presented at the 2024 American Heart Association (AHA) Scientific Sessions showed that continuous treatment with acoramidis (Attruby; BridgeBio Pharma) significantly reduced the risk of all-cause mortality (ACM) and cardiovascular-related hospitalizations (CVH) in patients with transthyretin amyloid cardiomyopathy (ATTR-CM).
Atrial fibrillation | Image credit: ibreakstock - stock.adobe.com
December 5th 2024

Lifestyle Changes Ease AFib Symptoms but Don't Lower Burden vs Standard Care

Pearl Steinzor
Metformin and lifestyle changes show no significant impact on atrial fibrillation (AFib) burden or progression compared with standard care.
FDA headquarters | Image Credit: Grandbrothers - stock.adobe.com
November 25th 2024

FDA Approves Acoramidis for ATTR-CM

Patrick Campbell
With approval, acoramaidis (Attruby; BridgeBio Pharma) becomes the first agent with a label specifying near-complete stabilization of transthyretin (TTR).
Cardiovascular health | Image Credit: BillionPhotos.com - stock.adobe.com
November 25th 2024

Unfavorable Health-Related Social Needs Associated With Lower Cardiovascular Health Scores

Brooke McCormick
Adults with more unfavorable health-related social needs, such as unemployment or food insecurity, had a higher prevalence of low cardiovascular health, highlighting the importance of addressing social determinants to improve population health.
Heart examination | Image credit: Ngampol - stock.adobe.com
November 20th 2024

Elevated Stress Hyperglycemia Ratio Linked to Higher All-Cause Mortality After Cardiovascular Events

Pearl Steinzor
Evidence highlights the predictive value of the stress hyperglycemia ratio for mortality risk in patients with acute myocardial infarction, ischemic stroke, and acute heart failure.
Smoking health risk | Image credit: sorapop - stock.adobe.com
November 15th 2024

How Smoking Cessation Affects Cardiovascular Disease Risk Over Time

Pearl Steinzor
New study findings reveal that the risk of cardiovascular disease among light ex-smokers aligns quickly with never-smokers, while heavy ex-smokers may take over 25 years to reach the same level.
Stressed female employee | Image Credit: Charlie's - stock.adobe.com
November 6th 2024

Work-Related Stress Linked to Poor Cardiovascular Health

Brooke McCormick
A new study has linked work-related stress to poorer cardiovascular health, highlighting the need for workplace wellness programs to reduce the risk of cardiovascular disease.
Doctor holding heart_Pana Studio - stock.adobe.com.jpeg
October 24th 2024

Evaluating the American Heart Association’s PREVENT Equations: Enhancing CVD Risk Prediction

Pearl Steinzor
A new study assesses the prognostic accuracy of Predicting Risk of CVD EVENTs (PREVENT) equations for predicting cardiovascular disease (CVD) mortality in the US population.
Viet Le, PA-C, Intermountain Health
October 19th 2024

Fostering Interdisciplinary Communication: How Cardio-Renal-Metabolic Care Models Optimize Care Delivery

Kyle Munz
Viet Le, PA-C, Intermountain Health, gives insights into the benefits cardio-renal-metabolic care models provide for patients in need.
"acute coronary syndrome" written on tablet | Image Credit: ibreakstock - stock.adobe.com
October 16th 2024

CHEST 2024 Posters Reveal Disparities in Acute Coronary Syndrome Care, Outcomes

Brooke McCormick
Two posters presented at the CHEST 2024 annual meeting highlighted significant disparities in acute coronary syndrome care and outcomes among different racial, ethnic, and gender groups, underscoring the urgent need for targeted interventions to address these inequities.
AJMC
October 10th 2024

Impact of Functional Recovery on Patients Having Heart Surgery

Richard J. Snow, DO, MPH Lauren McKown, JD, MPH Geoffrey Blossom, MD Karen Vogel, MPA Amy Creighton, MS Jason Shriver, OT Linda Will, APN Katie Lentz, PT, DPT Elizabeth Snow, MPH Teresa Caulin-Glaser, MD
This article describes the positive impact that actively managing functional recovery has on postacute placement for patients undergoing coronary artery bypass surgery.
doc measuring BP in pregnant woman-Andrey Popov-stock.adobe.com.jpeg
October 3rd 2024

Association Between Hypertensive Disorders of Pregnancy, Cardiovascular Severe Maternal Morbidity During Delivery Hospitalization

Pearl Steinzor
Hemolysis, elevated liver enzymes, low platelet (HELLP) syndrome, and severe preeclampsia significantly elevate cardiovascular risk during delivery, study finds.
Measuring blood pressure | Image credit: Andrey Popov - stock.adobe.com
September 30th 2024

Stalled Progress in Reducing Black Mortality Rates: The Role of External Causes and COVID-19

Pearl Steinzor
Despite reductions in deaths from cancer and cardiovascular diseases, increased mortality from assaults, accidents, and the COVID-19 pandemic has widened disparities in health outcomes for Black individuals.
Woman holding hand to heart in pain | Image credit: eddows – stock.adobe.com
September 24th 2024

Largest Study of Lp(a), Recurrent ASCVD Highlights Critical Risks and Need for Screening

Hayden E. Klein
Higher levels of lipoprotein(a) (Lp[a]) were found to be associated with a continuously increasing risk of recurrent atherosclerotic cardiovascular disease (ASCVD) events.
DNA double helix | Image credit: Dr_Microbe – stock.adobe.com
September 24th 2024

The Role of Genetics in Cholesterol, Heart Disease Risk

Hayden E. Klein
A collection of research by Helen Hobbs, MD, highlights how genetic mutations influence cholesterol levels and impact heart disease risk, offering insights into lifelong cardiovascular health management.
Homozygous familial hypercholesterolemia affects an estimated 1 in 300,000 individuals | image credit: iushakovsky - stock.adobe.com
September 24th 2024

A Silent Risk: The Critical Role of Awareness and Early Detection in Familial Hypercholesterolemia

Kyle Munz
September 24 celebrates Familial Hypercholesterolemia Awareness Day, which recognizes the importance of screening measures, education, and advocacy in a lesser-known, underdiagnosed cardiovascular condition.
Familial Hypercholesterolemia | Image credit: Richelle – stock.adobe.com
September 23rd 2024

A Decade of Progress in Familial Hypercholesterolemia Awareness, Treatment

Hayden E. Klein
On day 1 of the Family Heart Global Summit, speakers highlighted the critical need for awareness, early diagnosis, and innovative treatment options for familial hypercholesterolemia, sharing significant strides made in the field over the past decade.
Denver Colorado | Image Credit: © f11photo - stock.adobe.com
September 16th 2024

Institute for Value-Based Medicine®: Multifaceted Approach Can Help Patients Benefit From the Expanded Lipid-Lowering Toolbox

Christina Mattina
Clinicians, researchers, and payer experts convened in Aurora, Colorado, on August 13, 2024, for discussions on ensuring that the recent advancements in lipid management are making their way to patients.
Family in hospital | Image Credit: LIGHTFIELD STUDIOS - stock.adobe.com
September 9th 2024

Spouses, Relatives of Patients With GU Cancer Face Elevated Cardiovascular, Psychological Comorbidity Risks

Brooke McCormick
Spouses and first-degree relatives of patients with genitourinary (GU) cancers face increased risks of developing cardiovascular and psychological comorbidities, particularly within the first year of diagnosis.
Dr Ty Gluckman
September 5th 2024

Dr Ty J. Gluckman on Cardiovascular Prevention Barriers, Exciting Therapy Developments for 2025

Brooke McCormick
Ty J. Gluckman, MD, FACC, FAHA, of Providence St. Joseph Health, emphasizes the need for better prevention of cardiovascular risks and discusses upcoming advances in glucagon-like peptide 1 (GLP-1) therapies.
Inclisiran's twice-yearly cadence and physician administration have potential to improve adherence to treatment, which is a common challenge with cholesterol management. Image credit: Robert - stock.adobe.com
August 30th 2024

Inclisiran Significantly Lowers LDL-C in V-MONO Study

Rose McNulty
Twice-yearly inclisiran (Leqvio) monotherapy showed clinically meaningful and statistically significant LDL-C lowering in patients at low or moderate risk of atherosclerotic cardiovascular disease in the V-MONO study.
Semaglutide Ozempic injection blood sugar obesity - myskin - stock.adobe.com.jpeg
August 26th 2024

Medicare Semaglutide Coverage: Millions May Gain Access That Could Cost $145 Billion

Giuliana Grossi
Medicare has not clearly defined what constitutes "established cardiovascular disease," leading to variability in potential patient eligibility; therefore, researchers aimed to estimate the number of Medicare beneficiaries who would become newly eligible for semaglutide under different definitions.
Human brain digital illustration | Image Credit: Siarhei - stock.adobe.com
August 14th 2024

Anti-Inflammatory Diet Linked to Lower Dementia Risk, Better Brain Health in Patients With Cardiometabolic Diseases

Brooke McCormick
Patients with cardiometabolic diseases who follow an anti-inflammatory diet have better brain health and a lower risk of dementia.
Joseph Biggio, MD, system chair and service line leader for women's services, and system chair for maternal fetal medicine at Ochsner Health
August 5th 2024

Ochsner Health Wins HHS Hypertension Innovator Award for Connected MOM Program

Pearl Steinzor
Ochsner Health's Connected Maternity Online Monitoring (MOM) program has been recognized for its innovative approach in managing hypertension during pregnancy and postpartum.
Cardiac CT scan | Image credit: Cleveland Clinic
August 3rd 2024

Using Imaging—and AI—to Find Those at Risk of Cardiac Events

Mary Caffrey
A joint session with the Society for Cardiovascular Computed Tomography (SCCT) took place on the first day of the American Society for Preventive Cardiology 2024 Congress in Salt Lake City, Utah.
AJMC Q&A with Dr Martha Gulati | Background image credit: ipopba – stock.adobe.com
August 2nd 2024

In ASPC President’s Address, Dr Martha Gulati Reflects on Progress and Future Goals in Cardiology

Hayden E. Klein
Martha Gulati, MD, MS, discusses the accomplishments of the American Society of Preventive Cardiology (ASPC) during her presidency and emphasizes the importance of advancing preventive cardiology.
Michael Shapiro, DO, FASPC, Wake Forest University and ASPC president elect
July 31st 2024

ASPC Congress to Highlight Innovations in CVD Prevention

Maggie L. Shaw
In advance of this year’s American Society for Preventive Cardiology (ASPC) 2024 Congress on CVD Prevention, we spoke with ASPC President-Elect Michael Shapiro, DO, FASPC, about the many can't-miss sessions at this year's record-breaking event.
concept of heart issues-ArtemisDiana-stock.adobe.com.jpeg
July 29th 2024

Applying PREVENT Equations May Reduce Statin and Antihypertensive Therapy for 15.8 Million US Adults

Pearl Steinzor
Researchers identify potential reductions in statin and antihypertensive therapy eligibility using Predicting Risk of cardiovascular disease EVENTs (PREVENT) equations.
MedDiet on table | Image credit: monticellllo - stock.adobe.com
July 25th 2024

Mediterranean Diet May Optimize Heart Health Among Children, Adolescents

Pearl Steinzor
Interventions promoting adherence to the Mediterranean diet were associated with cardiometabolic biomarkers in children and adolescents, according to one study.
Patient using a smartwatch | Image Credit: sitthiphong - stock.adobe.com
July 20th 2024

Wearable Devices Heighten Symptom Monitoring, Health Care Visits for Atrial Fibrillation

Brooke McCormick
Patients with atrial fibrillation who use wearable devices, like Apple Watches and FitBits, report higher anxiety levels and increased health care usage than nonusers.
12345678
...
22>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo